Heart transplant vaccine study halted after just 4 patients
NCT ID NCT04845945
First seen Feb 04, 2026 · Last updated May 01, 2026 · Updated 13 times
Summary
This study looked at how well the pneumococcal vaccine works in people waiting for or who have received a heart transplant. Researchers used two blood tests to measure antibody levels after standard vaccination. Only 4 people took part before the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT INFECTION PREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montefiore Medical Center, Infectious Diseases
The Bronx, New York, 10467, United States
Conditions
Explore the condition pages connected to this study.